SIGA Technologies Inc SIGA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:45 AM EDT
7.99quote price arrow up+0.04 (+0.50%)
Volume
1,592
Close
7.95quote price arrow up+0.62 (+8.46%)
Volume
1,851,300
52 week range
4.22 - 7.96
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.95
  • 52 Week High7.96
  • 52 Week High Date03/18/24
  • 52 Week Low4.22
  • 52 Week Low Date09/12/23

Key Stats

  • Market Cap565.178M
  • Shares Out71.09M
  • 10 Day Average Volume1.24M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change41.96

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.95
  • 52 Week High7.96
  • 52 Week High Date03/18/24
  • 52 Week Low4.22
  • 52 Week Low Date09/12/23
  • Market Cap565.178M
  • Shares Out71.09M
  • 10 Day Average Volume1.24M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change41.96

RATIOS/PROFITABILITY

  • EPS (TTM)0.94
  • P/E (TTM)8.46
  • Fwd P/E (NTM)-
  • EBITDA (TTM)84.826M
  • ROE (TTM)37.09%
  • Revenue (TTM)139.917M
  • Gross Margin (TTM)87.69%
  • Net Margin (TTM)48.65%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date03/25/2024
  • Div Amount0.60
  • Split Date-
  • Split Factor-

Latest On SIGA Technologies Inc

 

Profile

MORE
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company’s lead product, TPOXX (oral TPOXX), is an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The Company does not have a manufacturing infrastructure and does not intend to develop one for the manufacture of TPOXX. It uses contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The...
Diem Nguyen Ph.D.
Chief Executive Officer, Director
Daniel Luckshire
Chief Financial Officer, Executive Vice President, Corporate Secretary
Dennis Hruby Ph.D.
Executive Vice President, Chief Scientific Officer
Jay Varma M.D.
Executive Vice President, Chief Medical Officer, Director
Address
31 East 62Nd Street
New York, NY
10065
United States

Top Peers

SYMBOLLASTCHG%CHG
ESPR
Esperion Therapeutics Inc
2.05-0.02-0.97%
HROW
Harrow Inc
10.49UNCHUNCH
AQST
Aquestive Therapeutics Inc
5.51-0.58-9.52%
TVTX
Travere Therapeutics Inc
7.18-0.31-4.14%
CSTL
Castle Biosciences Inc
18.95+0.09+0.50%